Purchase of low molecular weight heparins

This tender concerns a framework agreement for the procurement of low molecular weight heparins. The initial duration of the agreement is two years, commencing on March 15, 2025, and concluding on March 14, 2027. It is important to note that AZ Alma will join this agreement on December 31, 2025. The framework agreement includes the possibility of two extensions, each for a period of one year. The first extension would run from March 15, 2027, to March 14, 2028, and the second extension would cover the period from March 15, 2028, to March 14, 2029. These extensions are subject to tacit renewal. This means the agreement will automatically extend unless a party provides timely notification of non-renewal. Such notification must be given at least 90 calendar days before the end of the current contract period (either the initial term or a subsequent extension). Any termination of the agreement must be formally communicated via registered mail.

This is a supplies contract in the health and medical services and general supplies sectors, with a focus on Pharmaceuticals and Medical Equipment. Located in Belgium, Europe, this opportunity is open to firms and consortiums.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.